Centessa Pharmaceuticals Plc (CNTA)
39.54
-0.01
(-0.03%)
USD |
NASDAQ |
Apr 08, 16:00
39.54
0.00 (0.00%)
After-Hours: 16:31
Centessa Pharmaceuticals Total Assets (Quarterly) : 690.20M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biogen, Inc. | 29.44B |
| Eli Lilly & Co. | 112.48B |
| Apellis Pharmaceuticals, Inc. | 1.075B |
| Silence Therapeutics Plc | 131.44M |
| Adaptimmune Therapeutics Plc | 130.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 163.34M |
| Shareholders Equity (Quarterly) | 526.86M |
| Debt to Equity Ratio | 0.2247 |
| Current Ratio | 8.568 |
| Net Debt Paydown Yield | -0.18% |